Hewlett-Packard's medical sales regain vigour
This article was originally published in Clinica
After a flat 1994 for Hewlett-Packard's medical electronics sales, the first half of fiscal 1995 has seen renewed revenue growth in a division lagging the otherwise strongly-performing US electronics company. Medical electronics sales in the first quarter grew 15% to $328 million and 12% to $634 million in the first half.
You may also be interested in...
South Korea’s HLB has begun a new growth phase by taking over US-based clinical stage biotech firm Immunomic Therapeutics. Through the acquisition, it is poised to add new pipeline assets including a Phase II vaccine therapy for glioblastoma and proprietary lysosomal targeting technology.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.